Welcome to BioReagent Hub Hotline:19920083827
产品资料来源于品牌方官网 yeasen.com  |  仅供选型参考,规格与库存以官方最新信息为准
品官方资料 · 来源可溯查看原始页面 ›
Vendor Tel:400-6111-883
Product data sheet PD-91028ES
HiActi® Recombinant Human MCP‑3/CCL7 Protein  (CHO-expressed) 重组人CCL7 HiActi® Recombinant Human MCP‑3/CCL7 Protein  (CHO-expressed) 重组人CCL7
Enquiry

Tell us your volume and application; we reply with a quote.

Start enquiry

HiActi® Recombinant Human MCP‑3/CCL7 Protein (CHO-expressed) 重组人CCL7

Scan for product
CHO细胞表达系统单核细胞趋化研究巨噬细胞功能研究
Product no.91028ES Sizes2 options SourceYeasen · Official
Cat. No. 91028ES10
现货 ¥1,445.00
Qty 1
Enquire now
Enquire / bulk Compare

Specifications & Enquiry

Tick the specs you need to submit them together; or enquire one by one. Cat. numbers are carried into the RFQ.

Cat.No Spec Price Status
91028ES10 10 μg ¥1,445.00 现货 Enquire
91028ES50 50 μg ¥2,475.00 现货 Enquire
Submit enquiry Price is on application; bulk sizes can be sampled on request.

Overview

Specifications

Brand翌圣生物 Yeasen
Cat.No91028ES
Purity> 98% as analyzed by SDS-PAGE
Specification10 μg
Origin翌圣生物科技(上海)股份有限公司
技术平台 CHO细胞表达系统
应用方法 单核细胞趋化研究研究CCL7对单核细胞的趋化作用 巨噬细胞功能研究研究CCL7对巨噬细胞功能的调节作用
适用物种种属 人
检测方法 SDS-PAGE 胶凝法
生物特性参数 蛋白类型细胞因子/趋化因子 种属来源Human 生物活性描述CCL7特异性吸引单核细胞并调节巨噬细胞功能;通过CCR1、CCR2和CCR3受体发出信号。EC50值小于1.5 μg/ml(Ca2+ mobilization assay in CHO-K1/Gα15/hCCR1 cells)。 应用单核细胞趋化、巨噬细胞功能调节等研究
样本类型 重组蛋白
技术参数 表达系统CHO 表达序列Gln34-Leu109 纯度> 98% as analyzed by SDS-PAGE 分子量10~18 kDa on SDS-PAGE under reducing conditions. 内毒素水平< 1.0 EU/μg of protein by gel clotting method 制剂形式Lyophilized after extensive dialysis against PBS. 外观Lyophilized Powder 标签No Tag 活性The EC50 value of human MCP-3/CCL7 on Ca2+ mobilization assay in CHO-K1/Gα15/hCCR1 cells is less than 1.5 μg/ml. 储存条件-85 ~ -65℃保存,收到货之后有效期6个月。复溶后4°C稳定2周,-20°C稳定3个月。避免反复冻融循环。 复溶方法It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH₂O or PBS up to 100 μg/ml. AccessionQ7Z7Q8
实验类型 钙流检测实验检测生物活性

Recommended reading

Related products

✉Email 💬Message 👤Member
↑Top